VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
Go back to VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb| (NASDAQ: OABI) | Delayed: 4.54 -0.12 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.66 | 52 Week High | $ | |||
| Open | $4.66 | 52 Week Low | $ | |||
| Day High | $4.72 | P/E | N/A | |||
| Day Low | $4.53 | EPS | $ | |||
| Volume | 365,666 | |||||
| (NASDAQ: VRXA) | Delayed: 0.98 -0.02 (2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.95 | EPS | $ | |||
| Volume | 148,381 | |||||



